SecBot SecBot

AIFF

FIREFLY NEUROSCIENCE, INC.
Nasdaq· Services-Prepackaged Software· Inc. DE· CIK 0000803578 Software & IT
$0.9469 +0.03 (+2.92%)
Oct 26 4:00 PM ET · prev $0.9200
Market cap
$16.0M
Nano cap
1 year
−53.4%
from $2.03 · Oct 27
30 days
−44.0%
from $1.69
52-week range
$0.6400–3.02
−69% from high · low Feb 23
Avg volume 20D
301.9K
Sep 29 spike 1.31M
Short interest
1.10M
≈7.0% of shares · +265.0%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score
Strongest NEUTRAL Firefly Neuroscience announced a strategic collaboration with Radial, the operator of the largest U.S. brain…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBEARISH

    Q2 2026: 1 added (0 new), 4 trimmed or exited.

  • Short sellersBUILDING

    Short interest +265.0% to 1.10M shares. 1.0 days to cover, ≈7.0% of shares.

  • TrendDOWNTREND

    18% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADANEAR_EXIT1—
JANE STREET GROUP, LLCTRIM67,829$82.1K
UBS Group AGTRIM59,119$71.5K
NORTHERN TRUST CORPDOUBLED33,494$40.5K
CITIGROUP INCNEAR_EXIT2,091$2.5K
JANE STREET GROUP, LLCDOUBLED180,221$392.9K
BlackRock, Inc.ADD169,362$369.2K
GEODE CAPITAL MANAGEMENT, LLCADD156,308$340.8K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 30, 2026
Short interest
Short Interest: AIFF up 265% to 1.1M shares
Settlement 2026-09-30 | Days to cover: 1.00 | ≈7.00% of shares outstanding (est.)
Sep 25, 2026
Contract
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS ® System to Firefly’s nationwide network of Evoke™ clinicians –
Sep 17, 2026
M&A
Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine
– This integration of Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial’s August 2026 acquisition of the management…
Aug 5, 2026
Press release
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
Commercial momentum continues to build, while Firefly harnesses increased electrophysiological data combining EEG and ERG to unlock future value…
Jul 28, 2026
Contract
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week –

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Sep 25, 2026
POSNER BRIAN M
Director
AWARD84,033 sh
Sep 25, 2026
Menawat Arun Swarup
Director
AWARD126,050 sh
Sep 25, 2026
Vnook Stella
Director
AWARD84,033 sh
Mar 10, 2026
DeCaprio David
President and COO
AWARD44,872 sh
Mar 10, 2026
Lipschitz Gregory
Chief Executive Officer
AWARD65,988 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
1,098,284
shares short
+265.0%
vs prior settlement
1.0
days to cover
≈7.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Short interest report
Short Interest: AIFF up 265% to 1.1M shares
Settlement 2026-09-30 | Days to cover: 1.00 | ≈7.00% of shares outstanding (est.)
Sep 25, 2026 Press
Firefly Neuroscience announces a partnership with NeuroSigma to introduce the second-generation Monarch eTNS System to…
Impact 3/10
Sep 25, 2026 Insider
POSNER BRIAN M was granted 84,033 shares
Director
Sep 25, 2026 Insider
Menawat Arun Swarup was granted 126,050 shares
Director
Sep 25, 2026 Insider
Vnook Stella was granted 84,033 shares
Director
Sep 17, 2026 Press
Firefly Neuroscience announced a strategic collaboration with Radial, the operator of the largest U.S. brain medicine…
Impact 4/10
Jul 1, 2026 SEC
Firefly Neuroscience's S-3 registration statement (File No. 333-296046) became effective on June 30, 2026, allowing…
EFFECT — Impact 7/10
Jun 30, 2026 Inst.
ROYAL BANK OF CANADA — NEAR_EXIT
1 shares (—)

SecBot reports

6 filings · 3 press releases · 0 bullish · 4 bearish · 2 neutral
All AIFF filing & press-release reports (9)